Mid-South family succeeds in lobbying of FDA for new Duchenne drug

A Mid-South family is taking part in a huge victory this week for children with a rare disease.

Monday, the FDA approved the first drug to treat Duchenne Muscular Dystrophy going against the recommendations of its own doctors.

It's a move Dalton Al-Chokachi and his mother, Stacie, have fought to make happen, even testifying on Capitol Hill.